Author: Hassan Cesare Zullo Angelo Campo Salvatore MA Morini Sergio
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.15, Iss.4, 2005-04, pp. : 409-419
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Therapy of Crohn’s disease in childhood
By Beattie R Mark Bremner A Ronald F
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. :
Novel therapy for Crohn’s disease targeting IL-6 signalling
By Ito Hiroaki
Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. :
Infliximab: a biological breakthrough in Crohn's disease therapy
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :